Abstract:The expression of human telomerase reverse transcriptase (hTERT) is present in most malignant cells (>85%) but is undetectable in most normal somatic cells. Visualization of hTERT expression using radionuclide targeting can provide important diagnostic information in malignant tumors. The overall aim of this study was to evaluate whether 99mTc-radiolabeled antisense oligonucleotide (ASON) targeting hTERT messenger RNA (mRNA) can be used for imaging of hTERT expression in vivo. Methods: One 18-mer antisense or sense uniformly phosphorothioate-modified oligonucleotide targeting hTERT mRNA was radiolabeled with 99mTc through the bifunctional chelator N-hydroxysuccinimidyl derivative of S-acetylmercaptoacetyltriglycine (S-acetyl NHS-MAG3). Then the radiolabeled probe was characterized in vitro. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to assay the mRNA level after proliferating cells had been incubated with the antisense and sense probes. 99mTc-MAG3-ASON or 99mTc-MAG3-SON was injected intravenously in mammary tumor-bearing BALB/c nude mice. Biodistribution and in vivo imaging was performed periodically. All data were analyzed by statistical software. Results: The labeling efficiencies of 99mTc-MAG3-ASON/SON reached 76% ± 5% (n = 5) within 15–30 min at room temperature, the specific activity was up to 1,850 kBq/μg, and the radiochemical purity was >96% after purification. 99mTc-MAG3-ASON showed complete stability at room temperature and in fresh 37°C human serum. In comparison with 99mTc-MAG3-SON, 99mTc-MAG3-ASON preserved the capacity to bind living hTERT-expressing cells specifically and to inhibit the expression of hTERT mRNA significantly as well as ASON. In nude mice bearing hTERT-expressing MCF-7 xenografts, tumor radioactivity uptake of 99mTc-MAG3-ASON after injection was significantly higher than that of 99mTc-MAG3-SON after injection (P < 0.05). The hTERT-expressing xenografts were clearly imaged at 4–8 h noninvasively after injection of 99mTc-MAG3-ASON, whereas the xenografts were not imaged at any time after injection of 99mTc-MAG3-SON. Conclusion: This in vivo study provides evidence that 99mTc-MAG3-ASON targeting hTERT mRNA can be used as a potential candidate for visualization of hTERT expression in carcinomas.

Magnetic Resonance Tumor Targeting Imaging Using Gadolinium Labeled Human Telomerase Reverse Transcriptase Antisense Probes

Noninvasive Imaging of Human Telomerase Reverse Transcriptase (htert) Messenger Rna with (99)Mtc-Radiolabeled Antisense Probes in Malignant Tumors

Molecular Imaging and Pharmacokinetics of (99m) Tc-hTERT Antisense Oligonucleotide As a Potential Tumor Imaging Probe.

[In-Vivo Tumor Imaging by Radiolabeled RNA Probe Targeting Telomerase].

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Preparation and Tumor Cell Uptake of Sirna Probe Radiolabeled with Technetium-99m Targeting on Htert Gene

Study on in vivo imaging of 99Tcm-hTERT mRNA as antisense molecular probe in breast cancer tumor-bearing nude mice

A novel molecular probe:experimental study in vivo in nude mice bearing tumor

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Preparation and Characterization of 99Tcm-Labeled Antisense Oligonucleotide Targeting hTERT mRNA

MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

Study on Pharmacokinetics and Acute Toxicity of Human Telomerase Reverse Transcriptase Antisense Oligonucleotide Molecular Probe

Peptide Targeted Tripod Macrocyclic Gd(III) Chelates for Cancer Molecular MRI

A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM

Nagdf4 Nanoparticle-Based Molecular Probes for Magnetic Resonance Imaging of Intraperitoneal Tumor Xenografts in Vivo

Noninvasive Visualization Of Rna Delivery With Tc-99m-Radiolabeled Small Interference Rna In Tumor Xenografts

Coupling Gd-DTPA with a Bispecific, Recombinant Protein Anti-Egfr-irgd Complex Improves Tumor Targeting in MRI

A tumor-targetable probe based on europium(III)/gadolinium(III) complex-conjugated transferrin for dual-modal time-gated luminescence and magnetic resonance imaging of cancerous cells in vitro and in vivo

A novel near-infrared fluorescent probe for specific imaging of telomerase reverse transcriptase in vivo

A gadolinium-complex-based theranostic prodrug for in vivo tumour-targeted magnetic resonance imaging and therapy